ACR2022 - Day 2

2022-11-13

2023 RWCS MeetingDr. Arthur Kavanaugh invites you to join him for the 2023 RWCS meeting in February 2023. Dr David Liew JAK inhibitor VS TNF inhibitor, Infections in East Asian Patients.Abstract 302 Early Diagnosis of Axial SpondyloarthritisDr. Antoni Chan talks with Dr. Nelly Ziade at ACR22 Convergence in Philadelphia, PA.Abstracts 1512: What Is the Best Referral Strategy for Axial Spondyloarthritis? A Prospective Multicenter Study of 515 Patients with Suspicious Chronic Low Back ...

2023 RWCS Meeting
Dr. Arthur Kavanaugh invites you to join him for the 2023 RWCS meeting in February 2023.

Dr David Liew JAK inhibitor VS TNF inhibitor, Infections in East Asian Patients.
Abstract 302

Early Diagnosis of Axial Spondyloarthritis
Dr. Antoni Chan talks with Dr. Nelly Ziade at ACR22 Convergence in Philadelphia, PA.
Abstracts 1512: What Is the Best Referral Strategy for Axial Spondyloarthritis? A Prospective Multicenter Study of 515 Patients with Suspicious Chronic Low Back Pain
Abstract 1517: Value of the Anti-CD74 Antibodies for the Diagnosis of Axial Spondyloarthritis: Results of a Prospective Study in Patients with Suspicious Low Back Pain

New Treatments for SLE?
Dr. Michelle Petri discusses abstract 1117 presented at ACR22 Convergence meeting in Philadelphia, PA.
Abstract 1117: Efficacy and Safety of Deucravacitinib, an Oral, Selective, Allosteric TYK2 Inhibitor, in Patients with Active Systemic Lupus Erythematosus: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study

Comments (3)